Caryle via their specialist life sciences arm invested $170M USD into OPT after 9 months of due diligence (they only invest in 2-3 deals a year after assessing 100s). These are specialist investors and have much more biotech knowledge than 99% brokers / ppl on HC. Always DYOR but accept that these guys know what they are doing.
- Forums
- ASX - By Stock
- How high will this go?
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Caryle via their specialist life sciences arm invested $170M USD...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable